4,537 research outputs found
Structural and resistance switching properties of ZnO₃/ SrTiO/GaAs heterostructure grown by laser molecular beam epitaxy
Author name used in this publication: J. Y. Dai2010-2011 > Academic research: refereed > Publication in refereed journalVersion of RecordPublishe
The spectral variability of FSRQs
The optical variability of 29 flat spectrum radio quasars in SDSS Stripe 82
region are investigated by using DR7 released multi-epoch data. All FSRQs show
variations with overall amplitude ranging from 0.24 mag to 3.46 mag in
different sources. About half of FSRQs show a bluer-when-brighter trend, which
is commonly observed for blazars. However, only one source shows a
redder-when-brighter trend, which implies it is rare in FSRQs. In this source,
the thermal emission may likely be responsible for the spectral behavior.Comment: 4 pages, 1 figure, to be published in Journal of Astrophysics and
Astronomy, as a proceeding paper of the conference "Multiwavelength
Variability of Blazars", Guangzhou, China, September 22-24, 201
What do -ray bursts look like?
There have been great and rapid progresses in the field of -ray
bursts (denoted as GRBs) since BeppoSAX and other telescopes discovered their
afterglows in 1997. Here, we will first give a brief review on the
observational facts of GRBs and direct understanding from these facts, which
lead to the standard fireball model. The dynamical evolution of the fireball is
discussed, especially a generic model is proposed to describe the whole
dynamical evolution of GRB remnant from highly radiative to adiabatic, and from
ultra-relativistic to non-relativistic phase. Then, Various deviations from the
standard model are discussed to give new information about GRBs and their
environment. In order to relax the energy crisis, the beaming effects and their
possible observational evidences are also discussed in GRB's radiations.Comment: 10 pages, Latex. Invited talk at the Pacific Rim Conference on
Stellar Astrophysics, Hong Kong, China, Aug. 199
Suppressed Hysteretic Field Emission from Polymer Encapsulated Silver Nanowires
Suppression of the hysteretic electron emission in one-dimensional nanomaterial-based electron sources remains a critical barrier preventing their wide scale adoption in various vacuum electronics applications. Here, we report on the suppressed hysteretic performance, and its photo-dependence from conformal poly-vinylpyrrolidone encapsulated percolative Ag nanowire-based electron sources.This work was supported in part by the Oppenheimer Research Trust, Cambridge University, and an Impact Acceleration grant from the Engineering and Physical Sciences Research Council
Mitochondrial DNA Copy Number Is Associated with Breast Cancer Risk
Mitochondrial DNA (mtDNA) copy number in peripheral blood is associated with increased risk of several cancers. However, data from prospective studies on mtDNA copy number and breast cancer risk are lacking. We evaluated the association between mtDNA copy number in peripheral blood and breast cancer risk in a nested case-control study of 183 breast cancer cases with pre-diagnostic blood samples and 529 individually matched controls among participants of the Singapore Chinese Health Study. The mtDNA copy number was measured using real time PCR. Conditional logistic regression analyses showed that there was an overall positive association between mtDNA copy number and breast cancer risk (Ptrend = 0.01). The elevated risk for higher mtDNA copy numbers was primarily seen for women with <3 years between blood draw and cancer diagnosis; ORs (95% CIs) for 2nd, 3rd, 4th, and 5th quintile of mtDNA copy number were 1.52 (0.61, 3.82), 2.52 (1.03, 6.12), 3.12 (1.31, 7.43), and 3.06 (1.25, 7.47), respectively, compared with the 1st quintile (Ptrend = 0.004). There was no association between mtDNA copy number and breast cancer risk among women who donated a blood sample ≥3 years before breast cancer diagnosis (Ptrend = 0.41). This study supports a prospective association between increased mtDNA copy number and breast cancer risk that is dependent on the time interval between blood collection and breast cancer diagnosis. Future studies are warranted to confirm these findings and to elucidate the biological role of mtDNA copy number in breast cancer risk. © 2013 Thyagarajan et al
A Comprehensive Analysis of Electric Dipole Moment Constraints on CP-violating Phases in the MSSM
We analyze the constraints placed on individual, flavor diagonal CP-violating
phases in the minimal supersymmetric extension of the Standard Model (MSSM) by
current experimental bounds on the electric dipole moments (EDMs) of the
neutron, Thallium, and Mercury atoms. We identify the four CP-violating phases
that are individually highly constrained by current EDM bounds, and we explore
how these phases and correlations among them are constrained by current EDM
limits. We also analyze the prospective implications of the next generation of
EDM experiments. We point out that all other CP-violating phases in the MSSM
are not nearly as tightly constrained by limits on the size of EDMs. We
emphasize that a rich set of phenomenological consequences is potentially
associated with these generically large EDM-allowed phases, ranging from B
physics, electroweak baryogenesis, and signals of CP-violation at the CERN
Large Hadron Collider and at future linear colliders. Our numerical study takes
into account the complete set of contributions from one- and two-loop EDMs of
the electron and quarks, one- and two-loop Chromo-EDMs of quarks, the Weinberg
3-gluon operator, and dominant 4-fermion CP-odd operator contributions,
including contributions which are both included and not included yet in the
CPsuperH2.0 package. We also introduce an open-source numerical package, 2LEDM,
which provides the complete set of two-loop electroweak diagrams contributing
to the electric dipole moments of leptons and quarks.Comment: 23 pages, 11 figures; v2: references added, minor change
A fast and low-complexity matrix inversion scheme based on CSM method for massive MIMO systems
Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia
Copyright @ 2013 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Friedreich ataxia (FRDA) is an autosomal recessive disorder characterized by neurodegeneration and cardiomyopathy. The presence of a GAA trinucleotide repeat expansion in the first intron of the FXN gene results in the inhibition of gene expression and an insufficiency of the mitochondrial protein frataxin. There is a correlation between expansion length, the amount of residual frataxin and the severity of disease. As the coding sequence is unaltered, pharmacological up-regulation of FXN expression may restore frataxin to therapeutic levels. To facilitate screening of compounds that modulate FXN expression in a physiologically relevant manner, we established a cellular genomic reporter assay consisting of a stable human cell line containing an FXN-EGFP fusion construct, in which the EGFP gene is fused in-frame with the entire normal human FXN gene present on a BAC clone. The cell line was used to establish a fluorometric cellular assay for use in high throughput screening (HTS) procedures. A small chemical library containing FDA-approved compounds and natural extracts was screened and analyzed. Compound hits identified by HTS were further evaluated by flow cytometry in the cellular genomic reporter assay. The effects on FXN mRNA and frataxin protein levels were measured in lymphoblast and fibroblast cell lines derived from individuals with FRDA and in a humanized GAA repeat expansion mouse model of FRDA. Compounds that were established to increase FXN gene expression and frataxin levels included several anti-cancer agents, the iron-chelator deferiprone and the phytoalexin resveratrol.Muscular Dystrophy Association (USA), the National Health and Medical Research Council (Australia), the Friedreich’s Ataxia Research Alliance (USA), the Brockhoff Foundation (Australia), the Friedreich Ataxia Research Association (Australasia), Seek A Miracle (USA) and the Victorian Government’s Operational Infrastructure Support Program
- …